Zoetis (ZTS) Positioned Within Morgan Stanley’s 2026 Healthcare Playbook
Zoetis Inc. (NYSE:ZTS) is included among the 15 Dividend Stocks with Low Payout Ratios and Strong Upside. Zoetis (ZTS) Positioned Within Morgan Stanley’s 2026 Healthcare Playbook Budimir Jevtic/Shutterstock.com On December 18, Morgan Stanley lowered its price target on Zoetis Inc. (NYSE:ZTS) to 175 and kept an Overweight rating. In its year-ahead outlook, the firm said healthcare technology and providers offer an “attractive backdrop for alpha-generation opportunities” in 2026. Managed care i ...